x
Cure., a Deerfield affiliate and premier healthcare innovation ecosystem, recently launched the Cure Innovation Index. To our knowledge, this is the first systematic ranking of U.S. biomedical institutions by an array of critical factors associated with the successful translation of scientific research into real-world health impact.
The Index ranks the top 303 U.S. institutions using an evidence-based framework to quantify key elements that aims to help enable researchers to turn scientific discoveries into healthcare solutions with commercial and public health potential.
Turning science into breakthroughs
A collaboration aimed at accelerating the creation and development of therapeutics
Beth Israel Deaconess Medical Center (BIDMC) and Deerfield Management, a healthcare investment firm, announced a research collaboration named Brookline Avenue Innovations, LLC, aimed at accelerating the creation and development of novel therapeutics. Deerfield has committed up to $130 million along with additional scientific and operational support to this collaboration to advance BIDMC research that has the potential to transform patient care over the next decade.
BIDMC researchers will be able to submit proposals for funding to Deerfield’s scientific review team. Accepted proposals will work with Brookline Avenue Innovations to specifically manage and support BIDMC projects. Selected projects will also have the eligibility for additional capital investments to create spin-off companies.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,800 physicians and 36,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
Proposal Submissions
To learn more about project sourcing and evaluation, please reach out to Cindy Wong in the Technology Ventures Office at cwong2@bidmc.harvard.edu.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of Brookline Avenue and Deerfield, and has not been reviewed or approved by Brookline Avenue or Deerfield.